Jan 21, 2014

Regulatory Pathway for Biosimilar Products in Nigeria

In December 2012, the National Agency for Food and Drug Administration and Control (NAFDAC), which is Nigeria’s equivalent of the U.S. Food and Drug Administration (FDA), released a guidance document and guidelines for the registration of biosimilars in Nigeria. These documents were created in recognition of the need to ensure a pathway for biosimilars in Nigeria as […]
back to top